PapersPMID:31136659
Blueberries improve biomarkers of cardiometabolic function in participants with metabolic syndrome-results from a 6-month, double-blind, randomized controlled trial.
- findings
- 2
- compound
- 1
- endpoints
- 2
- Study, every finding
- RCT
What moved
How to read these marks →- Increases flow-mediated dilation
moderate
“However, after 6 mo of 1 cup blueberries/d %FMD significantly increased (1 cup: 1.45%; 1/2 cup: 0.00%; placebo: 0.39%; P = 0.003), and AIx significantly reduced, compared with other treatments (1 cup: –2.24%; 1/2 cup: 0.45%; placebo: 0.24%; P = 0.04).”
- Interests
- Industry funded
- Dose studied
- 26 g/day freeze-dried blueberry powder (1 cup, 150 g fresh equivalent; 364 mg anthocyanins, 879 mg phenolics) for 6 months versus 26 g isocaloric placebo powder
- Population
- Adults aged 50-75 years with metabolic syndrome; the 1 cup (150 g fresh-equivalent) dose arm only, compared across placebo and 1/2 cup arms, change over 6 months
- Increases triglycerides
moderate
“However, TG levels differed (P = 0.04; Table 2), with a significant increase in the 1/2-cup blueberry group compared with placebo (P = 0.01, Table 2); this remained when analysis was restricted to statin nonusers (P = 0.04; Supplemental Table 6).”
- Interests
- Industry funded
- Dose studied
- 13 g freeze-dried blueberry powder plus 13 g placebo material per day (1/2 cup, 75 g fresh equivalent; 182 mg anthocyanins) for 6 months versus 26 g placebo powder
- Population
- Adults aged 50-75 years with metabolic syndrome; the 1/2 cup (75 g fresh-equivalent) dose arm only, compared with placebo over 6 months
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Overweight and obese adults aged 50-75 y with metabolic syndrome (3 or more components), UK
- Participants
- 115
- Comparator
- placebo
- Duration
- 183 days
- Endpoints measured
- 65